Advances in Cancer Immunotherapy Subcommittee

 View Only
last person joined: 3 months ago 

The Advances in Cancer Immunotherapy™ (ACI) Committee oversees the planning and implementation of SITC’s regional introductory, CME-, CNE-, CPE- and MOC-certified programs created for the entire clinical cancer care team. The committee provides expert guidance to the appropriate audiences and timely content relevant to advancing patient care using FDA-approved immunotherapies.

ADVANCES IN CANCER IMMUNOTHERAPY WEBINAR SERIES

Chair
Christian M. Capitini, MD
University of Wisconsin-Madison

Co-Chair
Marianne Davies, DNP, AOCNP, FAAN
Yale School of Nursing